The University of Chicago Header Logo

Connection

Valluvan Jeevanandam to Aged

Back to Details
This is a "connection" page, showing publications Valluvan Jeevanandam has written about Aged.
Valluvan Jeevanandam
Connection Strength
1.610
Aged
  1. Anemia and outcomes following left ventricular assist device implantation. Artif Organs. 2022 Aug; 46(8):1626-1635.
    View in: PubMed
    Score: 0.063
  2. Impact of plasma volume status on mortality following left ventricular assist device implantation. Artif Organs. 2021 Jun; 45(6):587-592.
    View in: PubMed
    Score: 0.058
  3. An International Study on Ventricular Assist Device Program Models. Prog Transplant. 2020 12; 30(4):355-359.
    View in: PubMed
    Score: 0.057
  4. Perioperative improvement in serum albumin level in patients with left ventricular assist device. J Card Surg. 2020 Nov; 35(11):3070-3077.
    View in: PubMed
    Score: 0.057
  5. Opioid Use and Morbidities during Left Ventricular Assist Device Support. Int Heart J. 2020 May 30; 61(3):547-552.
    View in: PubMed
    Score: 0.056
  6. Effect of tobacco smoking on outcomes after left ventricular assist device implantation. Artif Organs. 2020 Jul; 44(7):693-699.
    View in: PubMed
    Score: 0.055
  7. Atrial Arrhythmias and Electroanatomical Remodeling in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2017 Mar 08; 6(3).
    View in: PubMed
    Score: 0.045
  8. Complex Tricuspid Valve Repair in Patients With Pacer Defibrillator-Related Tricuspid Regurgitation. Ann Thorac Surg. 2016 Apr; 101(4):1599-601.
    View in: PubMed
    Score: 0.042
  9. Prophylactic Subclavian Artery Intraaortic Balloon Counter-Pulsation is Safe in High-Risk Cardiac Surgery Patients. ASAIO J. 2015 Sep-Oct; 61(5):e36-9.
    View in: PubMed
    Score: 0.040
  10. The Subclavian Intraaortic Balloon Pump: A Compelling Bridge Device for Advanced Heart Failure. Ann Thorac Surg. 2015 Dec; 100(6):2151-7; discussion 2157-8.
    View in: PubMed
    Score: 0.040
  11. Cardiovascular surgery in Jehovah's Witness patients: The role of preoperative optimization. J Thorac Cardiovasc Surg. 2015 Oct; 150(4):976-83.e1-3.
    View in: PubMed
    Score: 0.040
  12. Beating heart totally endoscopic coronary artery bypass. Ann Thorac Surg. 2010 Jun; 89(6):1873-9; discussion 1879-80.
    View in: PubMed
    Score: 0.028
  13. Donor tricuspid annuloplasty during orthotopic heart transplantation: long-term results of a prospective controlled study. Ann Thorac Surg. 2006 Dec; 82(6):2089-95; discussion 2095.
    View in: PubMed
    Score: 0.022
  14. Failure modes of left ventricular reconstruction or the Dor procedure: a multi-institutional perspective. Eur J Cardiothorac Surg. 2006 Aug; 30(2):347-52.
    View in: PubMed
    Score: 0.021
  15. A one-year comparison of prophylactic donor tricuspid annuloplasty in heart transplantation. Ann Thorac Surg. 2004 Sep; 78(3):759-66; discussion 759-66.
    View in: PubMed
    Score: 0.019
  16. Rigid sternal fixation in the cardiac transplant population. J Thorac Cardiovasc Surg. 2003 Sep; 126(3):896-7.
    View in: PubMed
    Score: 0.018
  17. The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
    View in: PubMed
    Score: 0.017
  18. Circulatory assistance with a permanent implantable IABP: initial human experience. Circulation. 2002 Sep 24; 106(12 Suppl 1):I183-8.
    View in: PubMed
    Score: 0.017
  19. Implications of Heart Rate in Patients with Left Ventricular Assist Devices. Int Heart J. 2022; 63(1):56-61.
    View in: PubMed
    Score: 0.016
  20. Short-Term Ventricular Structural Changes Following Left Ventricular Assist Device Implantation. ASAIO J. 2021 02 01; 67(2):169-176.
    View in: PubMed
    Score: 0.015
  21. Alternate Approach to Concomitant Carotid and Coronary Disease: Perioperative IABP Use during Carotid Endarterectomy. Ann Vasc Surg. 2021 Apr; 72:663.e9-663.e13.
    View in: PubMed
    Score: 0.015
  22. Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices. ASAIO J. 2020 Nov/Dec; 66(10):1127-1136.
    View in: PubMed
    Score: 0.014
  23. Changes in regional myocardial function after coronary artery bypass graft surgery are predicted by intraoperative low-dose dobutamine echocardiography. Anesthesiology. 2000 Sep; 93(3):685-92.
    View in: PubMed
    Score: 0.014
  24. Neurohormonal Blockade During Left Ventricular Assist Device Support. ASAIO J. 2020 08; 66(8):881-885.
    View in: PubMed
    Score: 0.014
  25. Optimal cannula positioning of HeartMate 3 left ventricular assist device. Artif Organs. 2020 Dec; 44(12):e509-e519.
    View in: PubMed
    Score: 0.014
  26. Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial. Circ Heart Fail. 2020 04; 13(4):e006666.
    View in: PubMed
    Score: 0.014
  27. Hemodynamic Effects of Concomitant Mitral Valve Surgery and Left Ventricular Assist Device Implantation. ASAIO J. 2020 04; 66(4):355-361.
    View in: PubMed
    Score: 0.014
  28. Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2020 04 07; 9(7):e014801.
    View in: PubMed
    Score: 0.014
  29. Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2020 09; 110(3):918-924.
    View in: PubMed
    Score: 0.014
  30. HeartWare Ventricular Assist Device Cannula Position and Hemocompatibility-Related Adverse Events. Ann Thorac Surg. 2020 09; 110(3):911-917.
    View in: PubMed
    Score: 0.014
  31. Outcomes following left ventricular assist device exchange. J Card Surg. 2020 Mar; 35(3):591-597.
    View in: PubMed
    Score: 0.014
  32. Estimation of Central Venous Pressure by Pacemaker Lead Impedances in Left Ventricular Assist Device Patients. ASAIO J. 2020 01; 66(1):49-54.
    View in: PubMed
    Score: 0.014
  33. Combined Left Ventricular Assist Device and Coronary Artery Bypass Grafting Surgery: Should We Bypass the Bypass? ASAIO J. 2020 01; 66(1):32-37.
    View in: PubMed
    Score: 0.014
  34. Surgical device exchange provides improved clinical outcomes compared to medical therapy in treating continuous-flow left ventricular assist device thrombosis. Artif Organs. 2020 Apr; 44(4):367-374.
    View in: PubMed
    Score: 0.014
  35. Estimation of the Severity of Aortic Insufficiency by HVAD Flow Waveform. Ann Thorac Surg. 2020 03; 109(3):945-949.
    View in: PubMed
    Score: 0.014
  36. Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes. J Am Heart Assoc. 2019 11 19; 8(22):e013278.
    View in: PubMed
    Score: 0.014
  37. Hemodynamics of concomitant tricuspid valve procedures at LVAD implantation. J Card Surg. 2019 Dec; 34(12):1511-1518.
    View in: PubMed
    Score: 0.014
  38. Discordance Between Clinical Assessment and Invasive Hemodynamics in Patients With Advanced Heart Failure. J Card Fail. 2020 Feb; 26(2):128-135.
    View in: PubMed
    Score: 0.013
  39. Novel Formula to Calculate Three-Dimensional Angle Between Inflow Cannula and Device Body of HeartMate II LVAD. Ann Thorac Surg. 2020 01; 109(1):63-68.
    View in: PubMed
    Score: 0.013
  40. Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 09; 38(9):997-999.
    View in: PubMed
    Score: 0.013
  41. A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange field of research: artificial heart (clinical). J Artif Organs. 2019 Sep; 22(3):181-187.
    View in: PubMed
    Score: 0.013
  42. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
    View in: PubMed
    Score: 0.013
  43. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates. Circ Heart Fail. 2019 02; 12(2):e005094.
    View in: PubMed
    Score: 0.013
  44. Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events. Eur J Heart Fail. 2019 05; 21(5):655-662.
    View in: PubMed
    Score: 0.013
  45. Feasibility and utility of intraoperative epicardial scar characterization during left ventricular assist device implantation. J Cardiovasc Electrophysiol. 2019 02; 30(2):183-192.
    View in: PubMed
    Score: 0.013
  46. Intraoperative Use of Nondepolarizing Neuromuscular Blocking Agents During Cardiac Surgery and Postoperative Pulmonary Complications: A Prospective Randomized Trial. J Cardiothorac Vasc Anesth. 2019 Jun; 33(6):1673-1681.
    View in: PubMed
    Score: 0.013
  47. Improvement in Biventricular Cardiac Function After Ambulatory Counterpulsation. J Card Fail. 2019 Jan; 25(1):20-26.
    View in: PubMed
    Score: 0.013
  48. Repeated Ramp Tests on Stable LVAD Patients Reveal Patient-Specific Hemodynamic Fingerprint. ASAIO J. 2018 Nov/Dec; 64(6):701-707.
    View in: PubMed
    Score: 0.013
  49. Left Atrial Appendage Occlusion With Left Ventricular Assist Device Decreases Thromboembolic Events. Ann Thorac Surg. 2019 04; 107(4):1181-1186.
    View in: PubMed
    Score: 0.013
  50. Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
    View in: PubMed
    Score: 0.013
  51. HeartNet™ in an explanted heart of a Jehovah's Witness. J Card Surg. 2018 Nov; 33(11):765.
    View in: PubMed
    Score: 0.013
  52. Incidence and Outcomes of Postoperative Atrial Fibrillation After Left Ventricular Assist Device. ASAIO J. 2018 Sep/Oct; 64(5):581-585.
    View in: PubMed
    Score: 0.012
  53. Impact of Residual Valve Disease on Survival After Implantation of Left Ventricular Assist Devices. Ann Thorac Surg. 2018 12; 106(6):1789-1796.
    View in: PubMed
    Score: 0.012
  54. Echocardiographic Predictors of Hemodynamics in Patients Supported With Left Ventricular Assist Devices. J Card Fail. 2018 Sep; 24(9):561-567.
    View in: PubMed
    Score: 0.012
  55. HVAD: The ENDURANCE Supplemental Trial. JACC Heart Fail. 2018 09; 6(9):792-802.
    View in: PubMed
    Score: 0.012
  56. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
    View in: PubMed
    Score: 0.012
  57. Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio. ASAIO J. 2018 Mar/Apr; 64(2):140-146.
    View in: PubMed
    Score: 0.012
  58. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices. Dig Dis Sci. 2018 Jun; 63(6):1518-1524.
    View in: PubMed
    Score: 0.012
  59. Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device. J Card Fail. 2018 Apr; 24(4):249-254.
    View in: PubMed
    Score: 0.012
  60. Predictors of Hemodynamic Improvement and Stabilization Following Intraaortic Balloon Pump Implantation in Patients With Advanced Heart Failure. J Invasive Cardiol. 2018 02; 30(2):56-61.
    View in: PubMed
    Score: 0.012
  61. HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump. ASAIO J. 2018 Jan/Feb; 64(1):10-15.
    View in: PubMed
    Score: 0.012
  62. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation. Circ Heart Fail. 2017 Sep; 10(9).
    View in: PubMed
    Score: 0.012
  63. Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol. 2017 12 11; 3(12):1412-1424.
    View in: PubMed
    Score: 0.012
  64. Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States. Am J Transplant. 2017 Oct; 17(10):2559-2566.
    View in: PubMed
    Score: 0.011
  65. Tumor necrosis factor-a levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2018 01; 37(1):107-115.
    View in: PubMed
    Score: 0.011
  66. The Hemodynamic Effects of Aortic Insufficiency in Patients Supported With Continuous-Flow Left Ventricular Assist Devices. J Card Fail. 2017 Jul; 23(7):545-551.
    View in: PubMed
    Score: 0.011
  67. 3D Morphological Changes in LV and RV During LVAD Ramp Studies. JACC Cardiovasc Imaging. 2018 02; 11(2 Pt 1):159-169.
    View in: PubMed
    Score: 0.011
  68. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
    View in: PubMed
    Score: 0.011
  69. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):451-460.
    View in: PubMed
    Score: 0.011
  70. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg. 1996 Nov; 62(5):1268-75.
    View in: PubMed
    Score: 0.011
  71. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation. 1996 Nov 01; 94(9 Suppl):II227-34.
    View in: PubMed
    Score: 0.011
  72. Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival. Ann Thorac Surg. 2017 Mar; 103(3):725-733.
    View in: PubMed
    Score: 0.011
  73. Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding. Circulation. 2016 Jul 12; 134(2):141-52.
    View in: PubMed
    Score: 0.011
  74. Screening for Outflow Cannula Malfunction of Left Ventricular Assist Devices (LVADs) With the Use of Doppler Echocardiography: New LVAD-Specific Reference Values for Contemporary Devices. J Card Fail. 2016 Oct; 22(10):808-14.
    View in: PubMed
    Score: 0.011
  75. PCI in Patients Supported With CF-LVADs: Indications, Safety, and Outcomes. J Invasive Cardiol. 2016 Jun; 28(6):238-42.
    View in: PubMed
    Score: 0.011
  76. Elongation of chordae tendineae as an adaptive process to reduce mitral regurgitation in functional mitral regurgitation. Eur Heart J Cardiovasc Imaging. 2016 May; 17(5):500-9.
    View in: PubMed
    Score: 0.010
  77. Accurate Quantification Methods for Aortic Insufficiency Severity in Patients With LVAD: Role of Diastolic Flow Acceleration and Systolic-to-Diastolic Peak Velocity Ratio of Outflow Cannula. JACC Cardiovasc Imaging. 2016 06; 9(6):641-51.
    View in: PubMed
    Score: 0.010
  78. Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency. Catheter Cardiovasc Interv. 2016 Apr; 87(5):971-9.
    View in: PubMed
    Score: 0.010
  79. Visualization and measurement of mitral valve chordae tendineae using three-dimensional transesophageal echocardiography from the transgastric approach. J Am Soc Echocardiogr. 2015 Apr; 28(4):449-54.
    View in: PubMed
    Score: 0.010
  80. Can Intraoperative Transesophageal Echocardiography Predict Postoperative Aortic Insufficiency in Patients Receiving Implantable Left Ventricular Assist Devices? J Cardiothorac Vasc Anesth. 2015 Aug; 29(4):901-5.
    View in: PubMed
    Score: 0.010
  81. Impact of implantable transvenous device lead location on severity of tricuspid regurgitation. J Am Soc Echocardiogr. 2014 Nov; 27(11):1164-75.
    View in: PubMed
    Score: 0.009
  82. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014 Apr; 7(4):337-47.
    View in: PubMed
    Score: 0.009
  83. Acute kidney injury and mortality following ventricular assist device implantation. Am J Nephrol. 2014; 39(3):195-203.
    View in: PubMed
    Score: 0.009
  84. Mitral valve dynamics in severe aortic stenosis before and after aortic valve replacement. J Am Soc Echocardiogr. 2013 Jun; 26(6):606-14.
    View in: PubMed
    Score: 0.009
  85. Localizing mitral valve perforations with 3D transesophageal echocardiography. JACC Cardiovasc Imaging. 2013 Mar; 6(3):407-10.
    View in: PubMed
    Score: 0.009
  86. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. JACC Cardiovasc Interv. 2013 Jan; 6(1):84-9.
    View in: PubMed
    Score: 0.008
  87. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012 Jun 26; 125(25):3191-200.
    View in: PubMed
    Score: 0.008
  88. Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):951-5.
    View in: PubMed
    Score: 0.008
  89. Quantifying the incremental cost of complications associated with mitral valve surgery in the United States. J Thorac Cardiovasc Surg. 2012 Apr; 143(4):864-72.
    View in: PubMed
    Score: 0.008
  90. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011 Aug; 92(2):520-7; discussion 527.
    View in: PubMed
    Score: 0.008
  91. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010 Dec; 5(12):2154-65.
    View in: PubMed
    Score: 0.007
  92. Reasons for nonadherence to guidelines for aortic valve replacement in patients with severe aortic stenosis and potential solutions. Am J Cardiol. 2010 May 01; 105(9):1339-42.
    View in: PubMed
    Score: 0.007
  93. Real-time three-dimensional transesophageal echocardiography in valve disease: comparison with surgical findings and evaluation of prosthetic valves. J Am Soc Echocardiogr. 2008 Dec; 21(12):1347-54.
    View in: PubMed
    Score: 0.006
  94. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant. 2008 Jul; 27(7):753-9.
    View in: PubMed
    Score: 0.006
  95. Primary sternal plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg. 2004 Aug; 26(2):367-72.
    View in: PubMed
    Score: 0.005
  96. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg. 2001 May; 71(5):1442-7.
    View in: PubMed
    Score: 0.004
  97. L-type Ca2+ channel alpha 1c subunit isoform switching in failing human ventricular myocardium. J Mol Cell Cardiol. 2000 Jun; 32(6):973-84.
    View in: PubMed
    Score: 0.004
  98. The sarcoplasmic reticulum and the Na+/Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes. Circ Res. 1999 Mar 05; 84(4):435-44.
    View in: PubMed
    Score: 0.003
  99. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 1998 Jun 16; 97(23):2316-22.
    View in: PubMed
    Score: 0.003
  100. Eliminating bradyarrhythmias after orthotopic heart transplantation. Circulation. 1996 Nov 01; 94(9 Suppl):II278-82.
    View in: PubMed
    Score: 0.003
  101. Functional and morphologic adaptation of undersized donor hearts after heart transplantation. J Am Coll Cardiol. 1995 Sep; 26(3):737-42.
    View in: PubMed
    Score: 0.003
  102. Radiofrequency ablation of Wolff-Parkinson-White syndrome in a donor heart after orthotopic heart transplantation. J Heart Lung Transplant. 1994 Sep-Oct; 13(5):905-9.
    View in: PubMed
    Score: 0.002
  103. Endomyocardial biopsy under transesophageal echocardiographic guidance can be safely performed in the critically ill cardiac transplant recipient. Am J Cardiol. 1994 May 15; 73(13):1019-20.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.